Cargando…
Globally optimal trial design and risk sharing arrangements are key to avoiding opportunity costs of delay and enabling equitable, feasible and effective global vaccine research and implementation in current or future pandemics
Global vaccination in the face of pandemics such as COVID-19 and new variants is a race against time. Avoiding the opportunity costs of delay and the associated health, social, and downstream economic impacts is a challenge and an imperative. Failures to address the global challenges posed by COVID-...
Autor principal: | Eckermann, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792836/ https://www.ncbi.nlm.nih.gov/pubmed/36582386 http://dx.doi.org/10.3389/fpubh.2022.1085319 |
Ejemplares similares
-
Global Health Mentorship: Challenges and Opportunities for Equitable Partnership
por: Bain, Luchuo Engelbert, et al.
Publicado: (2023) -
Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines
por: Manriquez Roa, Tania, et al.
Publicado: (2021) -
Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access
por: Phelan, Alexandra L, et al.
Publicado: (2020) -
Commentary: Fulfilling the Promise of Global Access Licensing Principles to Enable Equitable Access
por: Ramachandran, Reshma
Publicado: (2022) -
PB2347: GLOBAL REPRESENTATION AMONG JOURNAL EDITORS IN HEMATOLOGY: ARE WE DIVERSE, EQUITABLE, AND INCLUSIVE?
por: Gómez-De León, A., et al.
Publicado: (2022)